untitled

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

*

(Incorporated in the Cayman Islands with limited liability)

(Stock code: 00853) VOLUNTARY ANNOUNCEMENT REPAYMENT OF TERM LOANS

This is a voluntary announcement made by MicroPort Scientific Corporation (the "Company").
References are made to (i) the circular of the Company dated 15 December 2013 (the "Circular") in relation to, among other things, the acquisition of the Business and the financial assistance provided by Otsuka, a substantial shareholder of the Company; and (ii) the announcement of the Company dated
3 November 2014. Capitalised terms used herein shall have the same meanings as those defined in the
Circular unless the context requires otherwise.
On 15 December 2013, pursuant to the Credit Agreement, Otsuka agreed to grant to the Company the Facilities amounting to US$200 million (equivalent to approximately HK$1.56 billion) for the purpose of financing the Acquisition. Two of the Term Loans of the Facilities, namely, Term A Loan and Term C Loan, with an aggregate principal amount of US$160 million, both have a maturity date falling one (1) year after drawdown. Both of Term A Loan and Term C Loan were drawn on 10 January 2014 and mature on 9 January 2015.
The Board hereby announces that by 9 January 2015, the Company has fully repaid the Term A Loan and the Term C Loan in the aggregate principal amount of US$160 million to Otsuka and all accrued and unpaid interests.
By Order of the Board

MicroPort Scientific Corporation Dr. Zhaohua Chang

Shanghai, the People's Republic of China, 9 January 2015
1

As at the date of this announcement, the executive Director is Dr. Zhaohua Chang; the non-executive Directors are Mr. Norihiro Ashida, Mr. Hiroshi Shirafuji and Ms. Weiwei Chen; and the independent non-executive Directors are Mr. Zezhao Hua, Mr. Jonathan H. Chou and Dr. Guoen Liu.

* for identification purpose only

2

distributed by